Oct 17, 2022 | Press Releases
Company Intends to Dramatically Expand Product Offerings into Bioelectronic Treatment of Nausea CEO to Host Investor Call/Webcast on Wednesday, October 19th at 1:30 PM PT / 4:30 PM ET SAN FRANCISCO – Tivic Health® Systems, Inc. (Nasdaq: TIVC) (“Tivic...
Oct 6, 2022 | Press Releases
SAN FRANCISCO – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that the company’s CEO will present at Fifth Bioelectronic Medicine...
Oct 6, 2022 | Press Releases
SAN FRANCISCO – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that the company’s CEO will present at Fifth Bioelectronic Medicine...
Aug 30, 2022 | Press Releases
SAN FRANCISCO – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that the company’s CEO will present at the upcoming 148th National...
Aug 30, 2022 | Press Releases
SAN FRANCISCO – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that the company’s CEO will present at the upcoming 148th National...
Aug 15, 2022 | Press Releases
265% growth in unit sales through direct-to-consumer channels, 97% overall revenue growth vs. Q2 2021 SAN FRANCISCO – Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a commercial-phase health technology company that develops and...